Fresh Equities
ANTISENSE THERAPEUTICS LIMITED

ANTISENSE THERAPEUTICS LIMITED

ASX:ANP

Last Capital Raise
Bidding Closed
Raised
Not Available
Last Close
Not Available
Market Cap at Close
Not Available
Relisted
Mar 12, 2019

Company Information

Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.

Type

Listed Company

GICS Sub-Industry

Pharmaceuticals

Head Office

6 Wallace Ave, Toorak VIC 3142, Australia

Pharmaceuticals
Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.



Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Archive
Support
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.